Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them
Drug-drug interactions (DDIs) are a common source of preventable medical errors in inpatient and outpatient settings of both developed and developing countries. When two or more drugs are simultaneously prescribed, interactions between their effects may result in preventable adverse events such as d...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Kerman University of Medical Sciences
2020-03-01
|
Series: | مجله انفورماتیک سلامت و زیست پزشکی |
Subjects: | |
Online Access: | http://jhbmi.ir/article-1-431-en.html |
_version_ | 1811176275007504384 |
---|---|
author | Zahra Niazkhani Parastoo Amiri Habibollah Pirnejad |
author_facet | Zahra Niazkhani Parastoo Amiri Habibollah Pirnejad |
author_sort | Zahra Niazkhani |
collection | DOAJ |
description | Drug-drug interactions (DDIs) are a common source of preventable medical errors in inpatient and outpatient settings of both developed and developing countries. When two or more drugs are simultaneously prescribed, interactions between their effects may result in preventable adverse events such as damages to vital organs, frequent hospitalizations, prolonged length of hospital stay, and increased care cost for both patients and healthcare systems. Clinical decision support systems (CDSSs) have a great potential to support care providers to identify and manage DDIs timely, and thereby, to improve the quality of decisions on medication prescriptions. In this opinion paper, we provide a concise review of efforts necessary for a successful design and development of a DDI-CDSS with particular focus on the Iranian healthcare context. We also touch upon the measures to consider in order to overcome some of the important challenges and barriers jeopardizing the design and application of DDI-CDSSs in Iran. |
first_indexed | 2024-04-10T19:49:24Z |
format | Article |
id | doaj.art-51b6e54f29024422b76966325d9dd5e2 |
institution | Directory Open Access Journal |
issn | 2423-3870 2423-3498 |
language | fas |
last_indexed | 2024-04-10T19:49:24Z |
publishDate | 2020-03-01 |
publisher | Kerman University of Medical Sciences |
record_format | Article |
series | مجله انفورماتیک سلامت و زیست پزشکی |
spelling | doaj.art-51b6e54f29024422b76966325d9dd5e22023-01-28T10:30:48ZfasKerman University of Medical Sciencesمجله انفورماتیک سلامت و زیست پزشکی2423-38702423-34982020-03-0164333342Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome ThemZahra Niazkhani0Parastoo Amiri1Habibollah Pirnejad2 Ph.D. in Medical Informatics, Associate Professor, Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran M.Sc. in Medical Informatics, Clinical Research Development Unit of Imam Hospital, Urmia University of Medical Sciences, Urmia, Iran Ph.D. in Medical Informatics, Associate Professor, Patient Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran Drug-drug interactions (DDIs) are a common source of preventable medical errors in inpatient and outpatient settings of both developed and developing countries. When two or more drugs are simultaneously prescribed, interactions between their effects may result in preventable adverse events such as damages to vital organs, frequent hospitalizations, prolonged length of hospital stay, and increased care cost for both patients and healthcare systems. Clinical decision support systems (CDSSs) have a great potential to support care providers to identify and manage DDIs timely, and thereby, to improve the quality of decisions on medication prescriptions. In this opinion paper, we provide a concise review of efforts necessary for a successful design and development of a DDI-CDSS with particular focus on the Iranian healthcare context. We also touch upon the measures to consider in order to overcome some of the important challenges and barriers jeopardizing the design and application of DDI-CDSSs in Iran.http://jhbmi.ir/article-1-431-en.htmlclinical decision support systemcdssdrug-drug interactionchallengesadvantagesreview |
spellingShingle | Zahra Niazkhani Parastoo Amiri Habibollah Pirnejad Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them مجله انفورماتیک سلامت و زیست پزشکی clinical decision support system cdss drug-drug interaction challenges advantages review |
title | Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them |
title_full | Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them |
title_fullStr | Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them |
title_full_unstemmed | Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them |
title_short | Drug-Drug Interaction Clinical Decision Support Systems: Advantages, Challenges and Barriers, and Strategies to Overcome Them |
title_sort | drug drug interaction clinical decision support systems advantages challenges and barriers and strategies to overcome them |
topic | clinical decision support system cdss drug-drug interaction challenges advantages review |
url | http://jhbmi.ir/article-1-431-en.html |
work_keys_str_mv | AT zahraniazkhani drugdruginteractionclinicaldecisionsupportsystemsadvantageschallengesandbarriersandstrategiestoovercomethem AT parastooamiri drugdruginteractionclinicaldecisionsupportsystemsadvantageschallengesandbarriersandstrategiestoovercomethem AT habibollahpirnejad drugdruginteractionclinicaldecisionsupportsystemsadvantageschallengesandbarriersandstrategiestoovercomethem |